At OBOS: Growing Objections to Makena Price Hike

Over at Our Bodies Our Blog, I have a post on the FDA’s approval of Makena (17-Hydroxyprogesterone or 17OHP) for prevention of preterm birth and the huge price hike that followed, with links to commentaries on the controversy, including calls for boycotts, questions about the March of Dimes’s role in supporting the approval, lots of good posts from The Preemie Primer blog, and a New England Journal of Medicine perspective piece decrying the potential impact on Medicaid and decrease in access to the drug as a result of the price hike.

Advertisement